Hypoglycemic and Hypolipidimic Effects of Spirulina Platensis, Phycocyanin, Phycocyanopeptide and Phycocyanobilin on Male Diabetic Rats
That observation ultimately reshaped the trajectory of the entire drug class, leading to obesity-specific formulations and, more recently, FDA approvals for additional chronic conditions
Others respond on their own terms, but the overall picture remains consistent
Gently swirl until fully dissolved
A Therapeutic Use Exemption (TUE) would be required for legitimate medical use by an athlete, but it is very difficult to obtain for S2 substances
If pancreatitis is suspected, discontinue SAXENDA and initiate appropriate management